Literature DB >> 10689124

HLA class II haplotype associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations.

E A Trachtenberg1, H Yang, E Hayes, M Vinson, C Lin, S R Targan, D Tyan, H Erlich, J I Rotter.   

Abstract

Ulcerative colitis (UC) and Crohn's disease (CD) are the clinical entities comprising idiopathic inflammatory bowel disease (IBD). Previous studies on the association of IBD and human leukocyte antigen (HLA) class II genes suggested a role for HLA in this disease. Here we present HLA class II (DRB1, DQB1, DQA1, DPB1) allele and haplotype distributions determined using the polymerase chain reaction and sequence-specific oligonucleotide probe methods. A total of 578 UC and CD Caucasian patients and controls from Jewish (Ashkenazi) and non-Jewish populations was examined. Our previously reported association of DR1-DQ5 with CD was attributable to DRB1*0103. A dramatic association with IBD and the highly unusual DRB1*0103-DQA1*0501-DQB1*0301 haplotype (OR = 6.6, p = 0.036) was found. The more common DR1 haplotype, DRB1*0103-DQA1*0101-DQB1*0501, was also associated with IBD (OR = 3.1, p = 0.014), a result suggesting that interaction between DR and DQ may determine the extent of disease risk. Our previously reported association of DR2 with UC was attributable to DRB1*1502 (OR = 2.6, p = 0.006). At the DPB1 locus, a significant association of DPB1*0401 with CD was observed for the combined populations (OR = 1.85, p = 0.007). These observations indicate that some class II alleles and haplotypes confer susceptibility to both UC and CD, implying common immunogenetic mechanisms of pathogenesis, while others confer risk to only one of these diseases, and illustrate the value of DNA HLA typing in disease susceptibility analyses.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689124      PMCID: PMC4524574          DOI: 10.1016/s0198-8859(99)00134-2

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  32 in total

1.  Genetic diversity within the HLA class II region: ten new DPB1 alleles and their population distribution.

Authors:  P V Moonsamy; V C Suraj; T L Bugawan; R K Saiki; M Stoneking; J Roudier; M M Magzoub; A V Hill; A B Begovich
Journal:  Tissue Antigens       Date:  1992-09

2.  HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease.

Authors:  G Bouma; A C Poen; M A García-González; G M Schreuder; R J Felt-Bersma; S G Meuwissen; A S Pena
Journal:  Immunogenetics       Date:  1998-05       Impact factor: 2.846

3.  Polymorphism, recombination, and linkage disequilibrium within the HLA class II region.

Authors:  A B Begovich; G R McClure; V C Suraj; R C Helmuth; N Fildes; T L Bugawan; H A Erlich; W Klitz
Journal:  J Immunol       Date:  1992-01-01       Impact factor: 5.422

4.  Cytokine gene polymorphisms in inflammatory bowel disease.

Authors:  E Louis; J Satsangi; M Roussomoustakaki; M Parkes; G Fanning; K Welsh; D Jewell
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

6.  Evidence for genetic heterogeneity in inflammatory bowel disease (IBD); HLA genes in the predisposition to suffer from ulcerative colitis (UC) and Crohn's disease (CD).

Authors:  G Bouma; M Oudkerk Pool; J B Crusius; G M Schreuder; H P Hellemans; B U Meijer; P J Kostense; M J Giphart; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1997-07       Impact factor: 4.330

7.  Mapping of a susceptibility locus for Crohn's disease on chromosome 16.

Authors:  J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas
Journal:  Nature       Date:  1996-02-29       Impact factor: 49.962

8.  Rapid HLA-DPB typing using enzymatically amplified DNA and nonradioactive sequence-specific oligonucleotide probes.

Authors:  T L Bugawan; A B Begovich; H A Erlich
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

9.  Linkage of Crohn's disease to the major histocompatibility complex region is detected by multiple non-parametric analyses.

Authors:  H Yang; S E Plevy; K Taylor; D Tyan; N Fischel-Ghodsian; C McElree; S R Targan; J I Rotter
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

10.  Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD).

Authors:  G Bouma; B Xia; J B Crusius; G Bioque; I Koutroubakis; B M Von Blomberg; S G Meuwissen; A S Peña
Journal:  Clin Exp Immunol       Date:  1996-03       Impact factor: 4.330

View more
  12 in total

Review 1.  Genetics of inflammatory bowel disease: current status and future directions.

Authors:  Thomas D Walters; Mark S Silverberg
Journal:  Can J Gastroenterol       Date:  2006-10       Impact factor: 3.522

2.  TNFSF15 is an ethnic-specific IBD gene.

Authors:  Yoana Picornell; Ling Mei; Kent Taylor; Huiying Yang; Stephan R Targan; Jerome I Rotter
Journal:  Inflamm Bowel Dis       Date:  2007-11       Impact factor: 5.325

Review 3.  Genetics of inflammatory bowel disease: the role of the HLA complex.

Authors:  Tariq Ahmad; Sara-E Marshall; Derek Jewell
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

Review 4.  Immunogenetic biomarkers in inflammatory bowel diseases: role of the IBD3 region.

Authors:  Manuel Muro; Ruth López-Hernández; Anna Mrowiec
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

5.  Associations of HLA class I alleles in Japanese patients with Crohn's disease.

Authors:  D Oryoji; T Hisamatsu; K Tsuchiya; J Umeno; S Ueda; K Yamamoto; T Matsumoto; M Watanabe; T Hibi; T Sasazuki
Journal:  Genes Immun       Date:  2014-11-06       Impact factor: 2.676

Review 6.  Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

Authors:  Peter Laszlo Lakatos; Simon Fischer; Laszlo Lakatos; Istvan Gal; Janos Papp
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

Review 7.  Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.

Authors:  Henry T Lynch; Randall E Brand; Gershon Y Locker
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 8.  Inflammatory bowel disease: genetic and epidemiologic considerations.

Authors:  Judy H Cho
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand.

Authors:  Jill A Hollenbach; Martha B Ladner; Koy Saeteurn; Kent D Taylor; Ling Mei; Talin Haritunians; Dermot P B McGovern; Henry A Erlich; Jerome I Rotter; Elizabeth A Trachtenberg
Journal:  Immunogenetics       Date:  2009-09-30       Impact factor: 2.846

10.  Validation of the interleukin-10 knockout mouse model of colitis: antitumour necrosis factor-antibodies suppress the progression of colitis.

Authors:  T Scheinin; D M Butler; F Salway; B Scallon; M Feldmann
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.